PECAM1 and neoplasm: The tumor partial oxygen pressure, VEGFR-2-positive cells, and CD31-positive cells in the combination group were lower than those in the single regimen-treated group, which demonstrated that angiogenesis in tumors was blocked.283 SCH772984 is an ERK inhibitor and has no effect on tumor growth.